Talk:Eric Rubin
This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page. |
This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||
|
New Biography for Eric J. Rubin
[edit]Eric Joseph Rubin (born 1958) is an American microbiologist and infectious disease specialist1. He is a Professor of Medicine at Harvard Medical School, an adjunct Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health and the Editor-in-Chief of the New England Journal of Medicine2 and NEJM Group.
Personal life Rubin was born and raised in Brockton, Massachusetts. His father, Morris Rubin, was a salesman and his mother, Paula (Schechet) Rubin, was a school librarian. He is married to Akiyo Fujii and has two children, Alexander and Daniel.
Education and career Rubin graduated from Brockton High School, Harvard College (AB, 1980) and Tufts University (MD and PhD, 1990).7 As a graduate student he studied the mechanism of action of botulinum toxins with D. Michael Gill. Rubin trained in Internal Medicine and Infectious Disease at the Massachusetts General Hospital and went on to postdoctoral work in John Mekalanos’ lab at Harvard Medical School.3,4 There he studied Vibrio cholerae, Haemophilus influenzae and Mycobacterium smegmatis. His postdoctoral work included collaborating on the development of a widely used transposition system based on the Himar1 transposon along with the methods for mapping mutations on a genome-wide basis.
Rubin joined the Department of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health in 1999, eventually becoming the Irene Heinz Given Professor and Chair of the Department. His lab studies mycobacterial physiology and virulence and has developed many of the genetic tools used to study Mycobacterium tuberculosis5 and related organisms. With collaborators, the lab has used these tools to address a wide range of questions about tuberculosis pathogenesis, non-tuberculous mycobacteria, and drug and vaccine development. 6 He is also an infectious disease clinician who sees patients at Brigham and Women’s Hospital, where he is an Associate Physician.
In 2019, Rubin was appointed Editor-in-Chief of the Journal, where he had previously served as an Associate Editor, and NEJM Group, the publishing division of the Massachusetts Medical Society. During the Covid-19 outbreak, the Journal added a weekly podcast9 and rapidly published many studies, including the first description of SARS-CoV-2, the causative virus. During Rubin’s tenure, NEJM Group has also launched two more publications, NEJM Evidence and NEJM AI.
Rubin has worked extensively in international settings and has been involved on advisory boards for several national and global organizations. He is a member of the American Academy of Microbiology, the American Association of Physicians, and the National Academy of Medicine. He also serves on the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC).10
References
- "Eric J. Rubin, MD, PhD – Brigham and Women's Hospital". physiciandirectory.brighamandwomens.org. Retrieved 2024-05-31.
- "Eric Rubin named editor-in-chief of New England Journal of Medicine". www.hsph.harvard.edu/news. 2019-06-19. Retrieved 2024-05-31.
- "Eric Rubin". hsph.harvard.edu. Retrieved 2024-05-31.
- "Eric Rubin". catalyst.harvard.edu. Retrieved 2024-05-31.
- "Eric Rubin". Google scholar Retrieved 2024-05-31.
- "Scientist at Work, Scientist at Play". Harvard Public Health Magazine. 2018-12-14. Retrieved 2024-05-31.
- NEJM Evidence - Retrieved 2024-05-31.
- NEJM AI - Retrieved 2024-05-31.
- NEJM Podcasts - Retrieved 2024-05-31.
- VRBPAC- Retrieved 2024-05-31.
Dawn-NEJMGroup (talk) 14:14, 31 May 2024 (UTC)
This edit request by an editor with a conflict of interest has now been answered. |
- Please comply with the relevant policy (WP:COI) by stating your conflict of interest on your user page. Axad12 (talk) 09:56, 16 August 2024 (UTC)
- Not done for now Multiple parts of the draft are currently unsourced. Ideally, especially for biographies of living people, every fact should be sourced somewhere. Also, many of the sources you give are either too vague (e.g. NEJM's podcast feed to source the fact that Rubin was appointed Editor-in-Chief(?) and that the podcast was launched during the Covid-19 outbreak) or too directly connected to the subject (Rubin's profile in multiple websites). A Google search is also not an acceptable source by itself. Chaotic Enby (talk · contribs) 09:55, 13 September 2024 (UTC)
Edit request 26-SEP-2024
[edit]This edit request by an editor with a conflict of interest was declined. The requested text's references are not formatted according to the citation style predominantly in use with the subject article (WP:CITEVAR). Any additions made to the article should have references formatted according to the style already in use with the article. Please see the Reply section below for more information about this issue. |
- Eric Joseph Rubin (born 1958) is an American microbiologist and infectious disease specialist.1 He is a Professor of Medicine at Harvard Medical School, an adjunct Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health2 and the Editor-in-Chief of the New England Journal of Medicine and NEJM Group. 3
- Personal life
- Rubin was born and raised in Brockton, Massachusetts. His father, Morris Rubin, was a salesman and his mother, Paula (Schechet) Rubin, was a school librarian. He is married to Akiyo Fujii and has two children, Alexander and Daniel.
- Education and career
- Rubin graduated from Brockton High School, Harvard College (AB, 1980) and Tufts University (MD and PhD, 1990).4 As a graduate student he studied the mechanism of action of botulinum toxins with D. Michael Gill. 5 Rubin trained in Internal Medicine and Infectious Disease at the Massachusetts General Hospital6 and went on to postdoctoral work in John Mekalanos’ lab at Harvard Medical School.7 There he studied Vibrio cholerae, Haemophilus influenzae and Mycobacterium smegmatis.8 His postdoctoral work included collaborating on the development of a widely used transposition system based on the Himar1 transposon along with the methods for mapping mutations on a genome-wide basis. 9
- Rubin joined the Department of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health in 1999, eventually becoming the Irene Heinz Given Professor and Chair of the Department. 10 His lab studies mycobacterial physiology and virulence and has developed many of the genetic tools used to study Mycobacterium tuberculosis and related organisms. 11 With collaborators, the lab has used these tools to address a wide range of questions about tuberculosis pathogenesis, non-tuberculous mycobacteria, and drug and vaccine development.12 He is also an infectious disease clinician who sees patients at Brigham and Women’s Hospital, where he is an Associate Physician. 13
- In 2019, Rubin was appointed Editor-in-Chief of the Journal, where he had previously served as an Associate Editor, and NEJM Group, the publishing division of the Massachusetts Medical Society. 14 During the Covid-19 outbreak, the Journal recorded several podcast episodes15 and rapidly published many studies, including the first description of SARS-CoV-2, the causative virus. 16 During Rubin’s tenure, NEJM Group has also launched two more publications, NEJM Evidence17 and NEJM AI.18
- Rubin has worked extensively in international settings and has been involved on advisory boards for several national and global organizations. He is a member of the American Academy of Microbiology, the American Association of Physicians, and the National Academy of Medicine.19 He also serves on the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC).20
- References
- 1. https://physiciandirectory.brighamandwomens.org/details/1279/eric-rubin-infectious_disease-boston
- 2. https://www.hsph.harvard.edu/profile/eric-rubin/
- 3. https://www.prnewswire.com/news-releases/eric-j-rubin-md-phd-named-editor-in-chief-of-the-new-england-journal-of-medicine--and-nejm-group-300871474.html
- 4. https://www.enterprisenews.com/story/news/local/2019/06/23/brockton-native-named-editor-in/4847232007/
- 5. https://www.fda.gov/media/155882/download
- 6. https://doctors.massgeneralbrigham.org/provider/eric-j-rubin/254559
- 7. https://mekalanoslab.med.harvard.edu/alumni/
- 8. https://www.fda.gov/media/155882/download
- 9. https://patents.justia.com/patent/6368830
- 10. https://www.hsph.harvard.edu/magazine/magazine_article/scientist-at-work-scientist-at-play/
- 11. https://www.hsph.harvard.edu/rubin-lab/research/
- 12. https://www.hsph.harvard.edu/rubin-lab/research/
- 13. https://physiciandirectory.brighamandwomens.org/details/1279/eric-rubin-infectious_disease-boston
- 14. https://www.prnewswire.com/news-releases/eric-j-rubin-md-phd-named-editor-in-chief-of-the-new-england-journal-of-medicine--and-nejm-group-300871474.html
- 15. https://www.nejm.org/do/10.1056/NEJMdo200326/full/
- 16. https://www.nejm.org/doi/full/10.1056/NEJMc2004794
- 17. https://www.nejm.org/doi/full/10.1056/NEJMe2118588
- 18. https://www.statnews.com/2023/12/11/nejm-ai-new-journal-artificial-intelligence-medicine/
- 19. https://www.fda.gov/media/155882/download
- 20. https://www.fda.gov/advisory-committees/vaccines-and-related-biological-products-advisory-committee/roster-vaccines-and-related-biological-products-advisory-committee Dawn-NEJMGroup (talk) 18:55, 26 September 2024 (UTC)
Reply 26-NOV-2024
[edit]- Your edit request could not be reviewed because the provided references are not formatted correctly.[a] The citation style predominantly used by the Eric Rubin article is Citation Style 1 (CS1). The citation style used in the edit request consists of bare URL's.[b] Any requested edit of yours which may be implemented will need to resemble the current style already in use in the article – in this case, CS1. (See WP:CITEVAR.) In the extended section below titled Citation style, I have illustrated two examples: one showing how the edit request was submitted, and another showing how requests should be submitted in the future:
Citation style
|
---|
In the example above there are three URL's provided with the claim statements, but these URL's have not been placed using Citation Style 1, which is the style predominantly used by the Eric Rubin article. Using this style, the WikiFormatted text should resemble the following:
In the example above the references have been formatted according to Citation Style 1, which shows the author, the source's name, date, etc., all information which is lost when only the links are provided. As Wikipedia is a volunteer project, edit requests such as yours are generally expected to have this formatting done before the request is submitted for review. |
- Additionally, several terms within the proposed text do not contain Wikilinks. Terms which mention universities, people or medical societies should have the requisite WikiLinks added to the proposed text.
- Kindly resubmit the edit request below at your earliest convenience, taking care to ensure that it makes use of CS1 and includes any missing Wikilinks. If you have any questions about this formatting please don't hesitate to ask myself or another editor.
Notes
- ^ The fault for this formatting error may have originated with the automated prompts used by the edit request template, which asks for a COI editor to "supply the URL of any references used". While the resulting omission of information would not be the fault of the requesting COI editor, it nevertheless remains their responsibility to supply the references formatted in the style used by the article.
- ^ The use of bare URLs as references is a style which is acceptable for use in Wikipedia. However, general practice dictates that the style already in use for an article be the one that is subsequently used for all future additions unless changed by editorial consensus.[1]
References
- ^ "WP:CITEVAR - Wikipedia:Citing sources". Wikipedia. 20 October 2018. Retrieved 22 October 2018.
Guideline: It is normal practice to defer to the style used by the first major contributor or adopted by the consensus of editors already working on the page, unless a change in consensus has been achieved. If the article you are editing is already using a particular citation style, you should follow it.
Regards, Spintendo 09:50, 26 November 2024 (UTC)
- Eric Joseph Rubin (born 1958) is an American microbiologist and infectious disease specialist1. He is a Professor of Medicine at Harvard Medical School, an adjunct Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health and the Editor-in-Chief of the New England Journal of Medicine2 and NEJM Group.
- Personal life
- Rubin was born and raised in Brockton, Massachusetts. His father, Morris Rubin, was a salesman and his mother, Paula (Schechet) Rubin, was a school librarian. He is married to Akiyo Fujii and has two children, Alexander and Daniel.
- Education and career
- Rubin graduated from Brockton High School, Harvard College (AB, 1980) and Tufts University (MD and PhD, 1990).7 As a graduate student he studied the mechanism of action of botulinum toxins with D. Michael Gill. Rubin trained in Internal Medicine and Infectious Disease at the Massachusetts General Hospital and went on to postdoctoral work in John Mekalanos’ lab at Harvard Medical School.3,4 There he studied Vibrio cholerae, Haemophilus influenzae and Mycobacterium smegmatis. His postdoctoral work included collaborating on the development of a widely used transposition system based on the Himar1 transposon along with the methods for mapping mutations on a genome-wide basis.
- Rubin joined the Department of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health in 1999, eventually becoming the Irene Heinz Given Professor and Chair of the Department. His lab studies mycobacterial physiology and virulence and has developed many of the genetic tools used to study Mycobacterium tuberculosis5 and related organisms. With collaborators, the lab has used these tools to address a wide range of questions about tuberculosis pathogenesis, non-tuberculous mycobacteria, and drug and vaccine development. 6 He is also an infectious disease clinician who sees patients at Brigham and Women’s Hospital, where he is an Associate Physician.
- In 2019, Rubin was appointed Editor-in-Chief of the Journal, where he had previously served as an Associate Editor, and NEJM Group, the publishing division of the Massachusetts Medical Society. During the Covid-19 outbreak, the Journal added a weekly podcast9 and rapidly published many studies, including the first description of SARS-CoV-2, the causative virus. During Rubin’s tenure, NEJM Group has also launched two more publications, NEJM Evidence and NEJM AI.
- Rubin has worked extensively in international settings and has been involved on advisory boards for several national and global organizations. He is a member of the American Academy of Microbiology, the American Association of Physicians, and the National Academy of Medicine. He also serves on the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC).10
- 1. "Eric Rubin, MD, PhD". Brigham and Women's Hospital Physician Directory. Brigham and Women's Hospital. Retrieved 2024-12-27.
- 2. "Eric Rubin". Harvard T.H. Chan School of Public Health. Harvard University. Retrieved 2024-12-27.
- 3. "Eric J. Rubin, MD, PhD, Named Editor-in-Chief of the New England Journal of Medicine and NEJM Group" (Press release). PR Newswire. 2019-06-12. Retrieved 2024-12-27.
- 4. "Brockton native named editor-in-chief of New England Journal of Medicine". The Enterprise. Gannett. 2019-06-23. Retrieved 2024-12-27.
- 5. "Vaccines and Related Biological Products Advisory Committee October 14-15, 2021 Meeting Roster". U.S. Food and Drug Administration. U.S. Department of Health and Human Services. 2021-10-14. Retrieved 2024-12-27.
- 6. "Eric J. Rubin, MD, PhD". Mass General Brigham. Mass General Brigham. Retrieved 2024-12-27.
- 7. "Alumni". Mekalanos Lab. Harvard Medical School. Retrieved 2024-12-27.
- 8. "Vaccines and Related Biological Products Advisory Committee October 14-15, 2021 Meeting Roster". U.S. Food and Drug Administration. U.S. Department of Health and Human Services. Retrieved 2024-12-27.
- 9. US 6368830, "Attenuated Streptococcus pneumoniae strain", assigned to Harvard College
- 10. "Scientist at Work, Scientist at Play". Harvard T.H. Chan School of Public Health. Harvard University. 2019-10-01. Retrieved 2024-12-27.
- 11. "Rubin Lab". Harvard T.H. Chan School of Public Health. Harvard University. Retrieved 2024-12-27.
- 12. "Rubin Lab". Harvard T.H. Chan School of Public Health. Harvard University. Retrieved 2024-12-27.
- 13. "Eric Rubin, MD, PhD". Brigham and Women's Hospital Physician Directory. Brigham and Women's Hospital. Retrieved 2024-12-27.
- 14. "Eric J. Rubin, MD, PhD, Named Editor-in-Chief of the New England Journal of Medicine and NEJM Group" (Press release). PR Newswire. 2019-06-12. Retrieved 2024-12-27.
- 15. "First Authorizing Statement from NEJM on COVID-19". The New England Journal of Medicine. Massachusetts Medical Society. 2020-03-30. Retrieved 2024-12-27.
- 16. "Covid-19 — Reassessing the Risks to Health Care Workers". The New England Journal of Medicine. Massachusetts Medical Society. 2020-03-17. Retrieved 2024-12-27.
- 17. "COVID-19 — A Year of Uncertainty and Hope". The New England Journal of Medicine. Massachusetts Medical Society. 2021-12-22. Retrieved 2024-12-27.
- 18. "NEJM Launches New Journal Focused on Artificial Intelligence in Medicine". STAT News. STAT. 2023-12-11. Retrieved 2024-12-27.
- 19. "Vaccines and Related Biological Products Advisory Committee October 14-15, 2021 Meeting Roster". U.S. Food and Drug Administration. U.S. Department of Health and Human Services. 2021-10-14. Retrieved 2024-12-27.
- 20. "Roster for Vaccines and Related Biological Products Advisory Committee". U.S. Food and Drug Administration. U.S. Department of Health and Human Services. Retrieved 2024-12-27. Dawn-NEJMGroup (talk) 20:39, 27 December 2024 (UTC)
- Biography articles of living people
- Stub-Class biography articles
- Stub-Class biography (science and academia) articles
- Unknown-importance biography (science and academia) articles
- Science and academia work group articles
- WikiProject Biography articles
- Stub-Class United States articles
- Unknown-importance United States articles
- Stub-Class United States articles of Unknown-importance
- WikiProject United States articles
- Implemented requested edits
- Declined requested edits